Bayer
€45.40Change from previous close: −5.32%Absolute change: −€2.55
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- €44.6B
- Enterprise value
- €80.58B
- P/E (trailing 12 months)
- -25.4
- Forward P/E
- 9.41
- PEG
- 4.65
- Price/book
- 1.51
- Price/sales
- 0.98
- EV/EBITDA
- 7.95
- EV/revenue
- 1.78
Profitability and growth
- Gross margin
- 60.5%
- Operating margin
- 9.2%
- Net margin
- -3.8%
- ROE
- -5.7%
- ROA
- 3.2%
- Revenue growth (year over year)
- 1.2%
Financial health
- Total cash
- €5.08B
- Total debt
- €38.43B
- Debt/equity
- 1.29
- Current ratio
- 1.04
- Quick ratio
- 0.67
Dividends
- Annual dividend per share
- €0.11
- Dividend yield
- 0.2%
- Payout ratio
- 163.3%
- Ex-dividend date
- April 27, 2026
Analysts and estimates
- Average price target
- €58.22
- Median price target
- €58.50
- High price target
- €70.00
- Low price target
- €46.00
- Number of analysts
- 18
- Consensus
- Buy
- Forward EPS
- €4.83
- EPS estimate, current year
- €4.53
Shares and trading
- Beta
- 0.83
- Average volume
- 2.22M
- Shares outstanding
- 982.42M
- Float
- 982.42M
- Institutional ownership
- 61.5%
- Insider ownership
- 0.0%